• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Financial and emotional cost of bronchopulmonary dysplasia.

作者信息

McAleese K A, Knapp M A, Rhodes T T

机构信息

Department of Radiology, University of Arizona Medical Center, Tucson.

出版信息

Clin Pediatr (Phila). 1993 Jul;32(7):393-400. doi: 10.1177/000992289303200702.

DOI:10.1177/000992289303200702
PMID:8365073
Abstract

Bronchopulmonary dysplasia (BPD) in infants with neonatal respiratory disease significantly increases the duration of hospitalization and cost of medical care. Early discharge on home oxygen therapy results in cost savings for third-party payers and the hospital, but adds financial and emotional burdens for the family. The median cost of initial hospitalization for 59 infants was $173,160 each. The median duration of home oxygen therapy was 92 days; the median cost was $5,195, compared with a projected cost of $46,920 for hospitalization for the same period. Two thirds of the 59 families experienced increased financial stress associated with marital status, reduced income, type of health insurance, and/or lack of respite or nursing help. Emotional stress was assessed in 26 (44%) of the families; one half coped well. Parents' perception of adequate insurance and stable income was significantly associated with positive coping. Providing home care for an infant with BPD on oxygen therapy is rewarding in many respects, but success requires appreciating its financial and emotional impact on families and providing them with social and financial support.

摘要

相似文献

1
Financial and emotional cost of bronchopulmonary dysplasia.
Clin Pediatr (Phila). 1993 Jul;32(7):393-400. doi: 10.1177/000992289303200702.
2
[Home oxygen therapy in children with bronchopulmonary dysplasia].
Rev Chil Pediatr. 1990 Sep-Oct;61(5):267-70.
3
Respiratory morbidity, healthcare utilisation and cost of care at school age related to home oxygen status.学龄期与家庭氧疗状态相关的呼吸系统发病率、医疗保健利用情况和照护费用。
Eur J Pediatr. 2011 Aug;170(8):969-75. doi: 10.1007/s00431-010-1381-6. Epub 2011 Jan 12.
4
Cost effectiveness of home management of bronchopulmonary dysplasia.支气管肺发育不良家庭管理的成本效益
Pediatrics. 1982 Aug;70(2):330-1.
5
Home oxygen therapy in infants with bronchopulmonary dysplasia: a prospective study.
Eur J Pediatr. 1997 Nov;156(11):878-82. doi: 10.1007/s004310050735.
6
Using a home oxygen weaning protocol and pCO to evaluate outcomes for infants with bronchopulmonary dysplasia discharged on home oxygen.使用家庭氧疗脱机方案和 pCO 评估支气管肺发育不良患儿出院后家庭氧疗的结局。
Pediatr Pulmonol. 2020 Dec;55(12):3293-3303. doi: 10.1002/ppul.25057. Epub 2020 Sep 15.
7
Home oxygen therapy. Outcome of infants discharged from NICU on continuous treatment.家庭氧疗。从新生儿重症监护病房出院后接受持续治疗的婴儿的治疗结果。
Clin Pediatr (Phila). 1989 Mar;28(3):113-8. doi: 10.1177/000992288902800301.
8
The changing face of bronchopulmonary dysplasia: Part 2. Discharging an infant home on oxygen.
Adv Neonatal Care. 2003 Apr;3(2):88-98. doi: 10.1053/adnc.2003.50018.
9
Controversy surrounding the use of home oxygen for premature infants with bronchopulmonary dysplasia.关于为患有支气管肺发育不良的早产儿使用家庭氧气的争议。
J Perinatol. 2004 Jan;24(1):36-40. doi: 10.1038/sj.jp.7211012.
10
[Home oxygen treatment of an infant with bronchopulmonary dysplasia].[支气管肺发育不良婴儿的家庭氧疗]
Ugeskr Laeger. 1988 May 16;150(20):1235-6.

引用本文的文献

1
Predischarge Betamethasone in Infants Diagnosed With Bronchopulmonary Dysplasia.对诊断为支气管肺发育不良的婴儿出院前使用倍他米松。
Pediatr Pulmonol. 2025 Jul;60(7):e71201. doi: 10.1002/ppul.71201.
2
Clinical Outcomes Through Two Years for Infants With Bronchopulmonary Dysplasia and Tracheomalacia.患有支气管肺发育不良和气管软化症的婴儿两年的临床结局
Pediatr Pulmonol. 2025 Jan;60(1):e27383. doi: 10.1002/ppul.27383. Epub 2024 Dec 5.
3
Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial.
西地那非用于有支气管肺发育不良风险的早产儿的安全性:一项II期随机试验的基本原理和方法
Contemp Clin Trials Commun. 2022 Oct 31;30:101025. doi: 10.1016/j.conctc.2022.101025. eCollection 2022 Dec.
4
Systematic review of the healthcare cost of bronchopulmonary dysplasia.支气管肺发育不良的医疗成本系统评价。
BMJ Open. 2021 Aug 10;11(8):e045729. doi: 10.1136/bmjopen-2020-045729.
5
Influences of environmental exposures on preterm lung disease.环境暴露对早产儿肺部疾病的影响。
Expert Rev Respir Med. 2021 Oct;15(10):1271-1279. doi: 10.1080/17476348.2021.1941886. Epub 2021 Jun 17.
6
Health Care and Societal Costs of Bronchopulmonary Dysplasia.支气管肺发育不良的医疗保健及社会成本
Neoreviews. 2018 Apr;19(4):e211-e223. doi: 10.1542/neo.19-4-e211.
7
Bronchopulmonary dysplasia.支气管肺发育不良。
Nat Rev Dis Primers. 2019 Nov 14;5(1):78. doi: 10.1038/s41572-019-0127-7.
8
Home Oxygen and 2-Year Outcomes of Preterm Infants With Bronchopulmonary Dysplasia.家庭氧疗对患有支气管肺发育不良的早产儿 2 年结局的影响。
Pediatrics. 2019 May;143(5). doi: 10.1542/peds.2018-2956. Epub 2019 Apr 11.
9
Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants.呋塞米暴露与早产儿支气管肺发育不良的预防。
J Pediatr. 2019 May;208:134-140.e2. doi: 10.1016/j.jpeds.2018.11.043. Epub 2018 Dec 20.
10
Tracheobronchomalacia Is Associated with Increased Morbidity in Bronchopulmonary Dysplasia.气管支气管软化与支气管肺发育不良的发病率增加相关。
Ann Am Thorac Soc. 2017 Sep 1;14(9):1428-35. doi: 10.1513/AnnalsATS.201702-178OC. Epub 2017 Jun 16.